| RS886042899 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS886042901 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS886042902 |
COL6A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, COL6A1-related disorder |
| RS886042903 |
CAPN3
|
Health Risk |
Likely pathogenic |
— |
| RS886042904 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS886042906 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS886042907 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS886042916 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Hereditary hemorrhagic telangiectasia |
| RS886042920 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS886042922 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 1A, Myosclerosis |
| RS886042923 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS886042924 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS886042927 |
CAPN3
|
Health Risk |
Pathogenic |
— |
| RS886042930 |
VPS13B
|
Health Risk |
Pathogenic |
— |
| RS886042931 |
ALDH5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS886042932 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS886042933 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042935 |
RB1
|
Health Risk |
Pathogenic |
— |
| RS886042943 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042945 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886042951 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886042954 |
SYNE1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886042958 |
GDF5
|
Health Risk |
Likely pathogenic |
Grebe syndrome, Grebe syndrome |
| RS886042960 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS886042961 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS886042964 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886042968 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886042970 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042976 |
PLOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS886042977 |
EP300
|
Health Risk |
Likely pathogenic |
— |
| RS886042979 |
ROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042983 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Dilated cardiomyopathy 3B |
| RS886042995 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042996 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 1A, Bethlem myopathy 1A |
| RS886042997 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043000 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS886043002 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
EAST syndrome, EAST syndrome |
| RS886043003 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS886043009 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043010 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043011 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043012 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS886043022 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS886043023 |
NDP
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS886043031 |
SGCD
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS886043041 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS886043045 |
PCCA
|
Health Risk |
Likely pathogenic |
— |
| RS886043046 |
NIPBL
|
Health Risk |
Pathogenic |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS886043051 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043052 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886043058 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pendred syndrome, Pendred syndrome |
| RS886043059 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 2, Retinal dystrophy |
| RS886043061 |
CLN8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS886043063 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS886043066 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043068 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS886043074 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS886043076 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS886043080 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS886043083 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS886043084 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043086 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS886043087 |
SIL1
|
Health Risk |
Pathogenic |
— |
| RS886043088 |
ASS1
|
Health Risk |
Pathogenic |
— |
| RS886043090 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS886043091 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS886043095 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS886043096 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome |
| RS886043097 |
NDP
|
Health Risk |
Pathogenic/Likely pathogenic |
Atrophia bulborum hereditaria, Atrophia bulborum hereditaria |
| RS886043098 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS886043100 |
DCLRE1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS886043102 |
RECQL4
|
Health Risk |
Pathogenic |
— |
| RS886043103 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1B, Maple syrup urine disease type 1B |
| RS886043106 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043109 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Emery-Dreifuss muscular dystrophy 2 |
| RS886043110 |
POMT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS886043112 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS886043113 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043114 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Bethlem myopathy 1A |
| RS886043118 |
STAT1
|
Health Risk |
Pathogenic |
Immunodeficiency 31B, Immunodeficiency 31B |
| RS886043123 |
ACVRL1
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia, Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia |
| RS886043129 |
GRIN2A
|
Health Risk |
Pathogenic |
— |
| RS886043130 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS886043131 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043133 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043136 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS886043138 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS886043139 |
HYCC1
|
Health Risk |
Pathogenic |
— |
| RS886043143 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886043144 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886043145 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Distal myopathy with anterior tibial onset |
| RS886043146 |
SMCHD1
|
Health Risk |
Pathogenic |
— |
| RS886043147 |
COL6A1
|
Health Risk |
Pathogenic |
— |
| RS886043148 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS886043149 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043155 |
LRMDA
|
Health Risk |
Pathogenic |
— |
| RS886043157 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886043158 |
FLNB
|
Health Risk |
Pathogenic |
— |
| RS886043162 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886043164 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |